Emcure Pharmaceuticals Limited
Incorporated in 1981, Emcure Pharmaceuticals Limited is an Indian company that develops, manufactures, and markets a wide range of pharmaceutical products globally across several major therapeutic areas.
What Emcure files
- Others61
- Investor Meet33
- Updates23
- Important22
- Board Meeting10
- JV/Acquisition9
Emcure Pharmaceuticals Limited has informed the Exchange regarding Allotment of 11400 Shares.
Emcure Pharmaceuticals announced its 45th Annual General Meeting (AGM) via video conference. The Annual Report for FY 2025-26 is available online. Shareholders with physical shares need to update KYC; also, submit documents for TDS exemption on the final dividend.
Emcure Pharmaceuticals will participate in a physical meeting with a group of institutional investors in Pune.
CARE Ratings Limited has reaffirmed Emcure Pharma's Long-term and Short-term bank facilities at CARE AA; Stable / CARE A1+. The stable outlook reflects the company's healthy business profile, diversified revenue of ₹9,322 Cr in FY26 (+18% YoY), and improved profitability with a 20% PBILDT margin. Strong capital structure and strategic...
Newspaper Advertisement of Notice of the 45th Annual General Meeting and e-voting information